BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:07 PM
 | 
May 20, 2008
 |  BC Extra  |  Top Story

FDA approves Entereg for POI

FDA approved an NDA from Adolor (NASDAQ:ADLR) and partner GlaxoSmithKline (LSE:GSK; NYSE:GSK) for Entereg alvimopan to treat postoperative ileus (POI) following partial large or small bowel resection surgery with primary...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >